JoVE - Journal of Visualized Experiments
JoVE Visualize
Contact Us

Withaferin a modulation of microglia autophagy mitigates neuroinflammation and enhances cognitive function in POCD

  • 0Department of Anesthesiology, The Second Affliated Hospital, Jiangxi Medical College, Nanchang University, 1# Minde Road, Nanchang, 330006, Jiangxi Privince, People's Republic of China.
Scientific Reports +

|

October 31, 2024

|

October 31, 2024

View abstract on PubMed

Summary

This summary is machine-generated.

Withaferin A, derived from Withania somnifera, reduces lipid droplet accumulation and neuroinflammation in mice with postoperative cognitive dysfunction (POCD), improving cognitive function. This natural compound shows promise for treating POCD.

Area Of Science

  • Neuroscience
  • Pharmacology
  • Immunology

Background

  • Postoperative cognitive dysfunction (POCD) is an increasing concern linked to global population aging and medical advancements.
  • Neuroinflammation, driven by lipid droplet accumulation in microglia, is a key factor in POCD-related nerve damage.
  • Current treatments for POCD are limited due to its complex pathogenesis.

Purpose Of The Study

  • To investigate the therapeutic potential of Withaferin A (WA) in mitigating POCD.
  • To explore the mechanisms by which WA affects microglial lipid metabolism and neuroinflammation.
  • To assess WA's efficacy in improving cognitive function in a POCD mouse model.

Main Methods

  • Administered Withaferin A (WA), derived from Withania somnifera, to a mouse model of POCD.
  • Analyzed hippocampal lipid droplet accumulation and interleukin-1β (IL-1β) expression.
  • Conducted in vitro studies on microglial autophagy and inflammatory factor production.

Main Results

  • WA significantly reduced lipid droplet accumulation in the hippocampus of POCD mice.
  • WA inhibited the expression of the inflammatory factor IL-1β and improved cognitive abilities in mice.
  • In vitro experiments demonstrated that WA enhances microglial autophagy, promoting lipid droplet degradation and reducing inflammation.

Conclusions

  • Withaferin A effectively ameliorates POCD symptoms by targeting microglial lipid metabolism and neuroinflammation.
  • WA's ability to enhance autophagy and reduce inflammatory factors offers a novel therapeutic avenue for POCD.
  • This research provides a foundation for developing WA-based strategies against cognitive impairments associated with aging and surgery.

Keywords: